ArticleCancers2025

Trastuzumab Deruxtecan in Previously Treated HER2-Low Metastatic Breast Cancer: Real-World Multicentric Study in the Portuguese Population.

Luísa Soares Miranda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.